title: Self-renewal and differentiation of mouse embryonic stem cells as measured by Oct 4 gene expression: effects of lif, serum-free medium, retinoic acid, and dbcAMP.
abstract: In this study we examined the interplay between serum, leukemia inhibitory factor (LIF), retinoic acid, and dibutyrl cyclic adenosine monophosphate (dbcAMP) in affecting IOUD2 embryonic stem cell self-renewal and differentiation as assessed by Oct 4 expression, and cell proliferation as measured by total cell protein. Removal of LIF, reduced levels of fetal calf serum (FCS), and addition of retinoic acid all induced embryonic stem cell differentiation as measured by reduced Oct 4 expression. Lower levels of retinoic acid (0.1-10 nM) promoted the formation of epithelial-like cells, whereas higher levels (100-10,000 nM) favored differentiation into fibroblastic-like cells. The effects of dbcAMP varied with the presence or absence of FCS and LIF and the concentration of dbcAMP. In FCS-containing media, a low level of dbcAMP (100 microM) increased self-renewal in the absence of LIF, but it had no effect in its presence. In contrast, at higher concentrations (1,000 microM dbcAMP), regardless of LIF, differentiation was promoted. A similar effect of dbcAMP was seen in the presence of retinoic acid. In media without FCS but with serum replacement supplements, there was no effect of dbcAMP. This study shows that the Oct 4 expression system of IOUD2 cells provides a novel, simple method for quantifying cellular differentiation.
authors.affiliation: Department of Physiology, National University of Ireland, Galway, University Road, Galway, Ireland.
authors.forename: S
authors.initials: S
authors.lastname: Faherty
authors.forename: M T
authors.initials: MT
authors.lastname: Kane
authors.forename: L R
authors.initials: LR
authors.lastname: Quinlan
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D016895:Culture Media, Serum-Free / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004622:Embryo, Mammalian / Q000166:cytology*; D018507:Gene Expression Regulation, Developmental; D015850:Interleukin-6 / Q000494:pharmacology; D053605:Leukemia Inhibitory Factor; D051379:Mice; D050814:Octamer Transcription Factor-3 / Q000378:metabolism*; D013234:Stem Cells / Q000502:physiology*; D014212:Tretinoin / Q000494:pharmacology
chemical_list: D016895:Culture Media, Serum-Free; D015850:Interleukin-6; D053605:Leukemia Inhibitory Factor; C507838:Lif protein, mouse; D050814:Octamer Transcription Factor-3; C494174:Pou5f1 protein, mouse; D014212:Tretinoin; D003994:Bucladesine